How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

19,017 results for

Pacemaker

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker. (PubMed)

Pulmonary vein isolation combined with spironolactone or renal sympathetic denervation in patients with chronic kidney disease, uncontrolled hypertension, paroxysmal atrial fibrillation, and a pacemaker. Atrial fibrillation (AF) commonly occurs in chronic kidney disease (CKD), occasioning adverse outcomes. Merging pulmonary vein isolation (PVI) and renal sympathetic denervation (RSD) may decrease the recurrence of AF in subjects with CKD and uncontrolled hypertension. We considered that RSD

2018 Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing

82. The Effect of Religious Intervention Using Prayer for Quality of Life and Psychological Status of Patients with Permanent Pacemaker. (PubMed)

The Effect of Religious Intervention Using Prayer for Quality of Life and Psychological Status of Patients with Permanent Pacemaker. The development of heart disease, followed by the pacemaker implantation, has reduced the quality and psychological problems for patients. Thus, the present study was conducted to determine the effect of prayer on the quality of life and the psychological status of patients with permanent pacemaker. This is a quasi-experimental study in which 75 patients were

2018 Journal of religion and health

83. Evaluation of the safety of MRI scans in patients undergoing dual-chamber pacemaker implantation (Full text)

Evaluation of the safety of MRI scans in patients undergoing dual-chamber pacemaker implantation The safety of magnetic resonance imaging (MRI) scans in patients undergoing dual-chamber pacemaker (Medtronic's EnRhythm MRI SureScan IPG (implantable pulse generator) and CapSureFix MRI pacing electrodes) implantation were evaluated. A total of 86 patients undergoing this pacemaker implantation who were admitted to Huanggang Hospital from June 2006 to March 2017 were continuously selected (...) . On average 6.8±2.3 months after the implantation, the first MRI scan was conducted. The mean scan time was 2.2±0.9 and mean duration was 45.6±12.3 min; mean follow-up visit period was 40.5±15.6 months, and after follow-up, all the abnormal symptoms of patients and pacemaker abnormalities after scans were recorded. Causes of receiving MRI scans included neurological diseases (27%), spinal diseases (14%), cancers (26%), joint injuries (25%) and visceral systems (8%). A total of 12 cases (14.0%) showed

2018 Experimental and therapeutic medicine PubMed

84. Inflammatory Pericardial Pseudocyst Secondary to Atrial Myocardial Perforation: A Rare Complication following Transvenous Pacemaker Implantation (Full text)

Inflammatory Pericardial Pseudocyst Secondary to Atrial Myocardial Perforation: A Rare Complication following Transvenous Pacemaker Implantation Pericardial cyst is an uncommon clinical-pathological entity, most often a congenital condition. We describe a case of an acquired iatrogenic pericardial pseudocyst following permanent pacemaker implantation secondary to atrial myocardial perforation. Diagnosis was achieved by a plain chest film, echocardiography, and computed tomography and confirmed

2018 Case reports in cardiology PubMed

85. A rare complication of pacemaker implantation (Full text)

A rare complication of pacemaker implantation Lead perforation is a life-threatening rare complication of pacemaker or defibrillator lead implantation. Clinical examination, electrocardiogram, device interrogation, echocardiography, chest x-ray, and chest computed tomography scan can help in the diagnosis. Clinicians should be aware because early diagnosis and treatment are the cornerstones for achieving a better outcome.

2018 Clinical Case Reports PubMed

86. Pacemaker lead endocarditis: A rare cause of relapsing brucellosis (Full text)

Pacemaker lead endocarditis: A rare cause of relapsing brucellosis Implantable cardioverter-defibrillator endocarditis is a rare and potentially life threatening complication of brucellosis of difficult management for clinicians. We report an unusual case of pacemaker-related endocarditis due to Brucella melitensis in a patient with previous history of neurobrucellosis. Our patient was admitted to a hospital with severe swelling of his pacemaker pocket implanted 8 years earlier for sick sinus (...) syndrome. Although pocket site cultures were positive for Brucella but blood cultures were not and serologic titer by the Rose Bengal test was positive. Transesophageal echocardiography showed two vegetations on the pacemaker leads. The patient was treated with doxycycline, rifampin and gentamicin with full recovery and the entire pacemaker apparatus was surgically explanted. Interestingly, two year prior this admission, the patient presented with meningoencephalitis diagnosed with neurobrucellosis

2018 IDCases PubMed

87. Medical and Ethical Concerns Regarding Pacemaker Implantation in a Patient with Substance Use Disorder (Full text)

Medical and Ethical Concerns Regarding Pacemaker Implantation in a Patient with Substance Use Disorder Medical and ethical dilemmas surrounding endocarditis and cardiac valve replacements related to intravenous drug use have been described often. Less well-described are dilemmas associated with pacemaker implantation in such patients. We describe a patient with a substance use disorder for whom a pacemaker was medically indicated.

2018 Cureus PubMed

88. Proposal of a New Electrode and Modality of Electrical Stimulation for Diaphragmatic Pacemakers. (PubMed)

Proposal of a New Electrode and Modality of Electrical Stimulation for Diaphragmatic Pacemakers. This report describes the implantation of a new design of intramuscular electrode to the diaphragm and introduces a new modality of electroventilation for diaphragmatic pacemaker.We used 22 Large White female pigs to test 68 electrodes that were implanted in the abdominal portion of the diaphragm by videolaparoscopy. Animals were submitted to a new protocol of electroventilation with an unpolarized

2018 Annals of Thoracic Surgery

89. Case presentation: implantation of cardiac resynchronization therapy pacemaker via the coronary sinus in a patient with triple valve replacement. (Full text)

Case presentation: implantation of cardiac resynchronization therapy pacemaker via the coronary sinus in a patient with triple valve replacement. In patients with triple valve replacement developing third-degree atrioventricular block (AVB), the most appropriate approach for permanent pacemaker implantation remains questionable.In this case presentation, we first described the approach of implantation of the cardiac resynchronization therapy pacemaker (CRT-P) via one bipolar pacing lead

2018 BMC Cardiovascular Disorders PubMed

90. Battery Malfunction of a Leadless Cardiac Pacemaker - A Worrisome Single-Center Experience. (PubMed)

Battery Malfunction of a Leadless Cardiac Pacemaker - A Worrisome Single-Center Experience. 29540439 2018 05 30 1524-4539 137 22 2018 May 29 Circulation Circulation Battery Malfunction of a Leadless Cardiac Pacemaker: Worrisome Single-Center Experience. 2408-2410 10.1161/CIRCULATIONAHA.117.033371 Richter Sergio S Department of Electrophysiology, Helios Heart Center, University of Leipzig, Germany. s.richter@med.uni-leipzig.de. Döring Michael M Department of Electrophysiology, Helios Heart (...) , Helios Heart Center, University of Leipzig, Germany. Hindricks Gerhard G Department of Electrophysiology, Helios Heart Center, University of Leipzig, Germany. eng Letter 2018 03 14 United States Circulation 0147763 0009-7322 atrial fibrillation cardiac pacing, artificial complications heart block pacemaker, artificial 2018 3 16 6 0 2018 3 16 6 0 2018 3 16 6 0 ppublish 29540439 CIRCULATIONAHA.117.033371 10.1161/CIRCULATIONAHA.117.033371

2018 Circulation

91. Leadless Pacemaker Implantation in a Pediatric Patient with Prolonged Sinus Pauses. (PubMed)

Leadless Pacemaker Implantation in a Pediatric Patient with Prolonged Sinus Pauses. Permanent cardiac pacing is the only effective solution for patients with symptomatic bradycardia and heart block. About 10% of patients undergoing implantation of the conventional pacing system develop complications related to the subcutaneous pocket or the leads and in pediatric patients lead problems may rise in up to 30% of the patients. The leadless pacemaker devices were developed in order to minimize some (...) of those complications. We present a case of an 11-year-old patient who presented after the sudden death of his older brother, with recurrent episodes of syncope and documented prolonged sinus pauses. The patient underwent percutaneous implantation of a leadless Micra™ pacemaker device with optimal results.

2018 Pediatric Cardiology

92. Dizziness in a patient with a permanent VVI pacemaker. (PubMed)

Dizziness in a patient with a permanent VVI pacemaker. A 83-year-old woman with a single-chamber pacemaker implanted 15 years earlier was brought to the ED due to symptomatic bradycardia. ECG continuous monitoring allowed the diagnosis of atrial fibrillation with complete atrioventricular block in the setting of a complete failure to capture. The differing timing cycles of pacing outputs can confirm that sensing is preserved in the absence of a pacemaker programmer.Copyright © 2017 Elsevier Inc

2018 American Journal of Emergency Medicine

93. A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation

A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more (...) . A Pilot Study: Preventing Adverse Remodelling Following Pacemaker Implantation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03422705 Recruitment Status : Not yet recruiting First Posted : February 6, 2018 Last Update

2018 Clinical Trials

94. Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy

Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies (...) before adding more. Pacemaker Therapy for Drug-refractory Symptoms in Mid-cavity Hypertrophic Cardiomyopathy The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03450252 Recruitment Status : Recruiting First Posted : March 1

2018 Clinical Trials

95. Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. (Full text)

Artefacts in 1.5 Tesla and 3 Tesla cardiovascular magnetic resonance imaging in patients with leadless cardiac pacemakers. There are limited data on patients with leadless cardiac pacemakers (LCP) undergoing magnetic resonance imaging. The aim of this prospective, single-center, observational study was to evaluate artefacts on cardiovascular magnetic resonance (CMR) images in patients with LCP.Fifteen patients with Micra™ LCP, implanted at least 6 weeks prior to CMR scan, were enrolled

2018 Journal of Cardiovascular Magnetic Resonance PubMed

96. Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. (PubMed)

Comparative study of acute and mid-term complications with leadless and transvenous cardiac pacemakers. Leadless cardiac pacemakers (LCPs) aim to mitigate lead- and pocket-related complications seen with transvenous pacemakers (TVPs).The purpose of this study was to compare complications between the LCP cohort from the LEADLESS Pacemaker IDE Study (Leadless II) trial and a propensity score-matched real-world TVP cohort.The multicenter LEADLESS II trial evaluated the safety and efficacy

2018 Heart Rhythm

97. Intermittent Anticoagulation Guided by Continuous Atrial Fibrillation Burden Monitoring Using Dual Chamber Pacemakers and Implantable Cardioverter-Defibrillators-Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) (PubMed)

Intermittent Anticoagulation Guided by Continuous Atrial Fibrillation Burden Monitoring Using Dual Chamber Pacemakers and Implantable Cardioverter-Defibrillators-Results from the Tailored Anticoagulation for Non-Continuous Atrial Fibrillation (TACTIC-AF) Chronic anticoagulation is recommended for atrial fibrillation (AF) patients with thromboembolic risk factors regardless of AF duration/frequency. Continuous rhythm assessment with pacemakers (PMs)/implantable cardioverter-defibrillators (ICDs

2018 Heart Rhythm

98. Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient. (PubMed)

Longitudinal Outcomes of Epicardial and Endocardial Pacemaker Leads in the Adult Fontan Patient. Placement of an epicardial pacemaker system is often preferred over an endocardial system in patients who have undergone a Fontan operation, but data are limited on how these two systems perform over time in patients with Fontan palliation. We performed a retrospective review of adults with Fontan palliation who had pacemaker implantation and interrogation data at Mayo Clinic from 1994 to 2014. Lead

2018 Pediatric Cardiology

99. Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry. (PubMed)

Permanent pacemaker use among patients with heart failure and preserved ejection fraction: Findings from the Acute Decompensated Heart Failure National Registry (ADHERE) National Registry. Heart failure with preserved ejection fraction may be associated with chronotropic incompetence, but little is known about the incidence and prevalence of permanent pacemaker use in this population or factors associated with its use.We analyzed patients with heart failure with preserved ejection fraction (ie (...) , left ventricular ejection fraction greater than 40%) from the ADHERE registry (2001-2006) linked with Medicare claims. We described the use of both prevalent and incident permanent pacemakers in heart failure with preserved ejection fraction and determined factors associated with pacemaker use with logistic regression models.Among 13,881 patients with heart failure with preserved ejection fraction, 3136 (22.6%) had a permanent pacemaker, and of these patients, 636 had a permanent pacemaker

2018 American Heart Journal

100. The uterine pacemaker of labor. (PubMed)

The uterine pacemaker of labor. The laboring uterus is generally thought to initiate contractions much similar to the heart, with a single, dedicated pacemaker. Research on human and animal models over decades has failed to identify such pacemaker. On the contrary, data indicate that instead of being fixed at a site similar to the sinoatrial node of the heart, the initiation site for each uterine contraction changes during time, often with each contraction. The enigmatic uterine "pacemaker (...) " does not seem to fit the standard definition of what a pacemaker should be. The uterine pacemaker must also mesh with the primary physiological function of the uterus - to generate intrauterine pressure. This requires that most areas of the uterine wall contract in a coordinated, or synchronized, manner for each contraction of labor. It is not clear whether the primary mechanism of the uterine pacemaker is a slow-wave generator or an impulse generator. Slow waves in the gut initiate localized

2018 Best practice & research. Clinical obstetrics & gynaecology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>